Page last updated: 2024-10-29

indomethacin and Child Mental Disorders

indomethacin has been researched along with Child Mental Disorders in 1 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
"To evaluate whether the presence of patent ductus arteriosus (PDA) in preterm infants worsens long-term neurodevelopmental outcomes."1.48Long-Term Neurodevelopment of Low-Birthweight, Preterm Infants with Patent Ductus Arteriosus. ( Casey, PH; Collins, RT; Gossett, JM; Lyle, RE; Rettiganti, M; Robbins, JM, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collins, RT1
Lyle, RE1
Rettiganti, M1
Gossett, JM1
Robbins, JM1
Casey, PH1

Other Studies

1 other study available for indomethacin and Child Mental Disorders

ArticleYear
Long-Term Neurodevelopment of Low-Birthweight, Preterm Infants with Patent Ductus Arteriosus.
    The Journal of pediatrics, 2018, Volume: 203

    Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclooxygenase Inhibitors; Ductus Arteriosus, Pate

2018